Articles Tagged with Los Angeles marijuana attorney

A lack of diversity in medical marijuana licensing has raised concerns in Maryland, specifically by a number of black state lawmakers – most recently including Gov. Larry Hogan (R) and Attorney General Brian E. Frosh (D).marijuana1

Simultaneously, the Washington Post reports that there have been calls by the head of the legislative black caucus to prohibit elected officials from participating in the industry. Officials who backed the measure are questioning a fellow politician who also supported the legislation – and then later was welcomed aboard a company seeking a license to cultivate and distribute the drug. Del. Cheryl Glenn says the failure of Del. Dan Morhaim to make his dual roles clear. Both Glenn and Morhaim are Democrats from Baltimore.

These issues combined have proven impediments in a legalization process that has been marked with numerous missteps and delays since Maryland voters approved medical marijuana three years ago. Now, the state is clearing 15 companies for cultivation of the drug and another 15 companies for marijuana processing. None of those 30 companies are owned or operated by an African American – despite the fact that one-third of the population in Maryland is black.  Continue reading

Intellectual property protections – like trademarks or innovations on creative marketing – is one of the many federal benefits afforded to legitimate businesses. Unfortunately, L.A. marijuana dispensaries have long been shut out from these sort of protections precisely because they haven’t been treated as if their operation is in fact legitimate. worldwidebrand

Thankfully, that is starting to change as states pass reforms that bolster the position of marijuana dispensaries – medicinal and recreational – in our communities.

The effect that is having on the marijuana industry is being explored in the Winter 2016 issue of the Washington and Lee Law Review. The study, “Trademark Laundering, Useless Patents and Other IP Challenges for the Marijuana Industry,” delves into some of the intellectual property challenges the marijuana industry faces and how the industry is tackling those issues today. Because cannabis remains a Schedule I narcotic under federal law, despite progressive state-level reforms, those who grow and sell the drug or its derivatives have found themselves unable to secure banking services, saddled with onerous tax burdens, unable to count on the enforcement of contracts they sign and trouble finding good marijuana lawyers who are willing to take on the complex and ever-changing regulatory landscape. In all of this, intellectual property protection has been largely put on the back burner. Continue reading

Last month, the U.S. Food and Drug Administration (FDA) quietly approved a drug called Syndros, which is a synthetic form of THC, the active ingredient in marijuana. Its use is limited to patients who are suffering from AIDS and cancer.laboratory

Syndros is the liquid version of a drug called Marinol, which was approved back in 1985 as a synthetic cannabinoid. However, Marinol only comes in pill form. Syndros is the liquid form. Marinol was approved in the mid-80s to treat the same conditions as Syndros.

Interestingly, the approval of this liquid synthetic came around the same time the U.S. Drug Enforcement Administration (DEA) refused to reclassify marijuana as anything but a Schedule I narcotic, despite petitions from lawmakers to knock it down to a Schedule II. In the agency’s refusal to take this action, officials cited lack of proof that marijuana serves any legitimate medical purpose. Yet we are making synthetic versions of it for uses that are clearly legitimate and medical? Continue reading

Speaking to a group of cannabis industry advocates and members, California Lt. Gov. Gavin Newsome implored them to participate in the campaign to pass the legalization of recreational marijuana, slated for the November ballot. He warned a failure on this front would not only set California back on the marijuana issue, it would set the nation back. voterinformation

Newsome said a change in the law is essential because of the utter failure of the so-called War on Drugs.

At a conference in Oakland, sponsored by the National Cannabis Industry Assn., approximately 2,000 entrepreneurs and industry activists nodded as Newsome described the existing drug policies in California and the U.S. as essentially a war on the poor and on minorities.  Continue reading